Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the
first inventor to file provisions of the AIA .
Non-Final Rejection
The Status of Claims:
Claims 1-9 are pending.
Claims 1-9 are rejected.
Claims 1-6 and 8 are objected.
DETAILED ACTION
1. Claims 1-9 are under consideration in this Office Action.
Priority
2. It is noted that this application is a 371 of PCT/EP2021/077319 10/04/2021 , which has a foreign priority document, EPO EP20200255.6 10/06/2020.
Drawings
3. None.
IDS
4. None.
Claim Objections
Claims 1-6, 8 are objected to because of the following informalities:
In claims 1-6, 8, the term “general” of the general formula is recited. This expression can be improper because the claims do not define how general the formula can be in the claims. The examiner recommends to remove the term” general” from the claims. Appropriate correction is required.
Claim Rejections - 35 USC § 112
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
Claims 1-9 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor, or for pre-AIA the applicant regards as the invention.
In claim 1-2, the portion “ Tol” of the ” p-TolSO2O” as the definition of the variable “X” is recited. This expression can be vague because the meaning of “Tol” could be interpreted differently. The examiner recommends to replace “Tol” with its proper chemical structure in the claim.
The Close Prior Art
The close prior art to the current invention is Brucoli et al (Bioorg. Med. Chem. 20 (2012) 2019–2024) which describes the following scheme:
PNG
media_image1.png
200
400
media_image1.png
Greyscale
. However, is Brucoli et al does not teach the stating material and intermediate compounds to produce the final product. So, it would have been unobvious over the claimed invetrion.
Conclusion
Claims 1-9 are rejected.
Claims 1-6 and 8 are objected.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to TAYLOR V OH whose telephone number is (571)272-0689. The examiner can normally be reached 8:00-5:00.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Andrew Kosar can be reached at 571-272-0913. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/TAYLOR V OH/Primary Examiner, Art Unit 1625
10/12/2025